Search

everythinglearnresearchcommunity

for

Search:↓

Atorvastatin reversed memory problems caused by cancer drug trastuzumab and improved its cancer-fighting abilities without causing hair loss.

Docetaxel slightly extends prostate cancer survival but has significant side effects and high cost.

Enhancing Tregs can protect against alopecia areata.

A patient with alopecia areata regrew hair after taking tofacitinib and showed changes in certain blood and skin markers.

Sintilimab with chemotherapy improves survival and response in advanced lung cancer but increases some side effects.

Pemigatinib may be effective for treating ZMYM2::FGFR1 fusion-positive leukemia.

Tofacitinib helped regrow hair in a patient with severe hair loss and improved their quality of life without side effects.

Azathioprine can help with relapses and disability in NMOSD but has more side effects and needs more research.

Bendamustine combined with rituximab is an effective and well-tolerated treatment for certain types of lymphoma.

Mogamulizumab can cause hair loss, often linked to a better treatment response.

Bevacizumab may worsen hypothyroidism, so thyroid function should be monitored during treatment.

Teriflunomide is an effective and generally safe oral treatment for relapsing MS, reducing relapses and slowing disability progression.

Adalimumab helped control a child's severe eye disease when other treatments failed.

Tofacitinib improved arthritis and partially improved hair loss in a lupus patient without side effects.

Epirubicin and cyclophosphamide cause more anemia and side effects than docetaxel and cyclophosphamide, but both are equally effective.

Alefacept showed some effectiveness for alopecia areata but needs more research.

The cancer drugs bortezomib and lenalidomide cause skin side effects in many patients.

Tofacitinib and methotrexate successfully treated a woman's severe skin, joint, and hair loss issues.

Ritlecitinib is effective and safe for treating severe alopecia areata in people aged 12 and older.

Tofacitinib helped a person with total body hair loss grow hair again without bad side effects.

Dabrafenib was effective and well tolerated in treating thyroid cancer with a specific mutation.

Tofacitinib effectively regrows hair in alopecia areata patients, especially in younger individuals, with manageable side effects.

The trial showed that a new under-the-tongue treatment for severe hair loss was somewhat effective in a small group of people.

Mitoxantrone is effective for treating acute leukemia, especially in older patients, with a lower risk of heart damage.

Ritlecitinib is safe and well-tolerated for treating alopecia areata in patients aged 12 and older.

IMG-007 helps regrow hair and reduce scalp inflammation in severe alopecia areata.

Tofacitinib is effective for treating alopecia areata, and starting treatment early may improve results.

Nivolumab treatment led to hair regrowth in a man with metastatic melanoma and alopecia areata.

Tofacitinib regrew hair in a man with total hair loss but raised cytokine levels, needing more research on possible side effects.

Tofacitinib successfully treated hair loss in a Crohn's disease patient who previously used adalimumab.